The Technical Analyst
Emmaus Life Sciences, [EMMA]
Exchange: Other OTC Sector: Healthcare Industry: Biotechnology
Emmaus Life Sciences, Price, Forecast, Insider, Ratings, Fundamentals & Signals
8.57% $0.100
/ 24 apr 2024 @ 15:42
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 5.36 mill |
| EPS: | -0.0800 |
| P/E: | -1.250 |
| Earnings Date: | Apr 25, 2024 |
| SharesOutstanding: | 53.64 mill |
| Avg Daily Volume: | 0.0107 mill |
| RATING 2024-04-24 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Sell | |
| P/E: | Buy | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.250 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -1.250 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0860 - 0.114 ( +/- 14.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-02-29 | Lee Willis C | Buy | 77 000 | Common stock, $0.001 par value |
| 2024-02-28 | Lee Willis C | Buy | 15 000 | Common stock, $0.001 par value |
| 2024-02-27 | Lee Willis C | Buy | 10 000 | Common stock, $0.001 par value |
| 2024-02-26 | Lee Willis C | Buy | 13 200 | Common stock, $0.001 par value |
| 2024-02-01 | Zwicker Ian Harvey | Buy | 100 000 | Options |
| INSIDER POWER |
|---|
| 83.86 |
| Last 100 transactions |
| Buy: 21 964 419 | Sell: 2 979 029 |
Forecast: